PSUSA/00001371/202506
Submitted by Anonymous (not verified) on 16 January 2026 - 15:42
PSUSA/00001371/202506
PSUSA/00001898/202506
Submitted by Anonymous (not verified) on 16 January 2026 - 15:41
PSUSA/00001898/202506
Human medicines European public assessment report (EPAR): Sugammadex Adroiq, sugammadex, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 16 January 2026 - 15:36
Human medicines European public assessment report (EPAR): Sugammadex Adroiq, sugammadex, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Ervebo, Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live), Date of authorisation: 11/11/2019, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 16 January 2026 - 15:35
Human medicines European public assessment report (EPAR): Ervebo, Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live), Date of authorisation: 11/11/2019, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 16 January 2026 - 15:32
Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 16 January 2026 - 15:10
Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 8, Status: Authorised
Mysimba
Submitted by Anonymous (not verified) on 16 January 2026 - 15:02
Mysimba
Human medicines European public assessment report (EPAR): Karvea, irbesartan, Date of authorisation: 26/08/1997, Revision: 49, Status: Authorised
Submitted by Anonymous (not verified) on 16 January 2026 - 14:42
Human medicines European public assessment report (EPAR): Karvea, irbesartan, Date of authorisation: 26/08/1997, Revision: 49, Status: Authorised
Human medicines European public assessment report (EPAR): Tauvid, flortaucipir (18F), Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 16 January 2026 - 14:15
Human medicines European public assessment report (EPAR): Tauvid, flortaucipir (18F), Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Guidance for rapporteurs and members of drafting groups of documents developed by the GMP/GDP Inspectors Working Group
Submitted by Anonymous (not verified) on 16 January 2026 - 14:07
Guidance for rapporteurs and members of drafting groups of documents developed by the GMP/GDP Inspectors Working Group